Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL02
- Pharmacological subgroupL02B
- Chemical subgroupL02BB
- Chemical substanceL02BB06Darolutamide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Serbia
ALIMS · 2 registrations
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
At a glance
- ATC code
- L02BB06
- Registers
- 10
- Historical lists
- 1
- Registrations
- 12
- With their own page
- 11
- Companies
- 9
All medicines with Darolutamide
Human medicines from every register that match Darolutamide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
12 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Nubeqa | United States | 300MG | tablet | Marketed | Bayer Healthcare |
| Nubeqa 300 MG Comprimidos Recubiertos con Pelicula | Spain | 300 mg | comprimido recubierto con película | Marketed | Bayer Ag |
| Nubeqa | European Union | Authorised | Bayer AG | ||
| Nubeqa 300 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Bayer AG | |
| Nubeqa | Canada | 300 MG | Tablet | Marketed | Bayer INC |
| Nubeqa | Brazil | Authorised | Bayer S.A. | ||
| NUBEQA F.C. Tablets 300 mg | Taiwan | 膜衣錠 | Authorised | 台灣拜耳股份有限公司 | |
| Nubeqa Film-Coated Tablet 300MG | Singapore | 300mg | tablet, film coated | Authorised | Bayer (South East Asia) Pte LTD |
| Nubeqa® | Serbia | 300mg | film tableta | Authorised | Bayer D.O.O. Beograd |
| Nubeqa® | Serbia | 300mg | film tableta | Authorised | Bayer D.O.O. Beograd |
| Nubeqa | Croatia | Marketed | |||
| Nubeqa | Saudi Arabia | Authorised | Orion Corporation, Orion Pharma |